Medical research: our publications on stem cells and cancers

Scientific publications allow us to share our discoveries with colleagues around the world.

With more than 150 publications since its creation, the IRHT has gained international recognition.

Publications Scientifiques, Cellules SouchesSome of our latest publications :

  1. Human Very Small Embryonic-Like Stem Cells Are Present in Normal Peripheral Blood of Young, Middle-Aged, and Aged Subjects.
    Sovalat H, Scrofani M, Eidenschenk A, Hénon P.
    Stem Cells Int. 2016; 2016:7651645.
  2. Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
    Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C.
    Bioorg Med Chem. 2013 Apr 1; 21(7):2135-44.
  3. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H, Scrofani M, Eidenschenk A, Pasquet S, Rimelen V, Hénon P.
    Exp Hematol. 2011 Apr; 39(4):495-505.
  4. Three-dimensional distribution patterns of CD34 antigen on nonactivated cord blood cells.
    Jung G, Wunder E, Dieterlen A, Hénon P, Jacquey S.
    Cytometry A. 2008 Jan; 73(1):16-21.
  5. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
    Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP.
    Cytotherapy. 2009;11(8):1002-15.
  6. Relative quantification of residual tumor cells by lightcycler real-time IgH PCR in autografted multiple myeloma patients.
    Rimelen V, Ferrand C, Debecker A, Sovalat H, Tancredi C, Eidenschenk A, Hénon P.
    Leukemia. 2005 Mar; 19(3):492-5.
  7. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M, Sovalat H, Bourderont D, Brunot A, Marr A, Lewandowski H, Chabouté V, Peter P, Henon P.
    Cytotherapy. 2004;6(6):571-83.
  8. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H, Racadot E, Ojeda M, Lewandowski H, Chabouté V, Hénon P.
    J Hematother Stem Cell Res. 2003 Oct;12(5):473-89.
  9. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
    Hénon PH, Sovalat H, Bourderont D.
    J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):62-7. Review.
  10. Human accessory cells have a humoral bystander effect on CAFC growing on murine feeder.
    Mazini L, Wunder E, Sovalat H, Jung G, Bourderont D, Bachorz J, Bearenzung M, Zanetti C, Hénon P.
    J Hematother Stem Cell Res. 2000 Oct;9(5):749-57.
  11. Comparative analysis of class I, II and III epitope-detecting CD34 monoclonal antibodies by quantitative flow cytometry.
    Sovalat H, Racadot E, Hénon P, Fuchs P, Lewandowski H, Billot M.
    Hematol Cell Ther. 1998 Dec;40(6):259-68.
  12. Mature accessory cells influence long-term growth of human hematopoietic progenitors on a murine stromal cell feeder layer.
    Mazini L, Wunder E, Sovalat H, Bourderont D, Baerenzung M, Bachorz J, Hénon P.
    Stem Cells. 1998;16(6):404-12.
  13. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P, Sovalat H, Bourderont D, Ojeda-Uribe M, Arkam Y, Wunder E, Raidot JP, Husseini F, Audhuy B.
    Stem Cells. 1998;16 Suppl 1:113-22.
  14. Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation.
    Hénon P, Sovalat H, Becker M, Arkam Y, Ojeda-Uribe M, Raidot JP, Husseini F, Wunder E, Bourderont D, Audhuy B.
    Br J Haematol. 1998 Nov;103(2):568-81. Erratum in: Br J Haematol 1999 Jul;106(1):264. Bouderont D [corrected to Bourderont D].
  15. Isolation and identification of two CD34+ cell subpopulations from normal human peripheral blood.
    Herbein G, Sovalat H, Wunder E, Baerenzung M, Bachorz J, Lewandowski H, Schweitzer C, Schmitt C, Kirn A, Hénon P.
    Stem Cells. 1994 Mar;12(2):187-97.
  16. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
    Wunder E, Sovalat H, Liang H, Becker M, Henon P.
    Prog Clin Biol Res. 1994;389:345-50.
  17. Positive selection of CD34+ cells: a short review of the immunoadsorption methods currently available for experimental and clinical use. Report on the “2nd European Workshop on stem Cell Methodology,” Mulhouse, France, May 3-7, 1993.
    Silvestri F, Wunder E, Sovalat H, Henon P, Serke S.
    J Hematother. 1993 Winter;2(4):473-81. Review.
  18. Report on the European Workshop on Peripheral Blood Stem Cell Determination and Standardization–Mulhouse, France, February 6-8 and 14-15, 1992.
    Wunder E, Sovalat H, Fritsch G, Silvestri F, Henon P, Serke S.
    J Hematother. 1992 Summer;1(2):131-42.
  19. Ambiguous patterns in cellular differentiation in a case of “M3 variant” leukemia.
    Parent X, Sovalat H, Beck-Wirth G, Jung G, Henon P.
    Nouv Rev Fr Hematol. 1991;33(4):303-6. Erratum in: Nouv Rev Fr Hematol 1991;33(6):430.